1 / 8Bajaj Broking is expecting a 19% upside on the Nifty 50 index for 2025. The firm has a target of 28,700 on the index over the next 12 months. The only downside risk to their prognosis, is an elongated time correction with limited price damage as we do not expect the Nifty to fall below the 22,500 – 21,700 range, the brokerage wrote in its note.
2 / 8The brokerage expects sectors like IT, Defence, Hospitals, Banks and Telecom to outperform, while calls Metals, Finance and Pharma as bargain buys. It has an underweight rating on FMCG.
3 / 8Based on this, Bajaj Broking has come out with a list of five stocks, which it highlights as its top picks for 2025. These stocks are likely to see potential upside between 20% to 40%. Here is a look at these names.
4 / 8Prestige Estates | Bajaj Broking says that Prestige Estates’ upcoming launches are expected to have a Gross Development Value (GDV) of ₹52,000 crore, potentially resulting in pre-sales of around ₹20,000 crore to ₹22,000 crore. On the charts, the brokerage said that it is on the cusp of a breakout above the bullish flat formation and offers a fresh entry opportunity. Bajaj Broking recommends buying the stock in the ₹1,810 – ₹1,880 range with a price target of ₹2,290. The price target implies a potential upside of 24% from current levels.
5 / 8HUDCO | Bajaj Broking said that tailwinds are emerging for HUDCO from the recent PMAY-2 scheme, which will translate into disbursements worth ₹75,000 crore to ₹1 lakh crore in the next three years, along with robust urban infra financing opportunities from NHAI projects announced by states. Incremental loan mix tilting towards high growth, high yielding urban infra assets is another positive. On the charts, HUDCO has generated a breakout above the falling channel, signalling resumption of the upmove and offers a fresh entry opportunity. Bajaj Broking recommends buying the stock between the ₹238 – ₹249 range for a price target of ₹314 in the next 12 months, which implies a potential upside of 29%.
6 / 8Laurus Labs | Laurus Labs is showing signs of a potential turnaround. It expects the second half of the year to be driven by a strong order book and the delivery of anticipated projects. On the charts, the company is on the cusp of breaking above the rounding formation, signalling resumption of the upmove and that offers a fresh entry opportunity, Bajaj Broking said. It recommends buying Laurus Labs in the ₹555 – ₹575 range for a price target of ₹710, implying a potential upside of 26% for the next 12 months.
7 / 8Himadri Specialty Chemicals | Bajaj Broking recommends buying the stock in the ₹525 – ₹545 range for a price target of ₹687, which implies a potential upside of 28% for the next 12 months. The development of first commercial plant with a 40,000 MTPA capacity for LFP Cathode Active Material is progressing as planned and is scheduled to be operational by Q3 FY27, the brokerage said. The stock has also broken above the supply line joining the highs of 2007 and 2018, highlighting strength.
8 / 8ITD Cementation | The company has a pipeline of around ₹30,000 crore in projects at various stages, with bids for projects between ₹12,000 crore to ₹13,000 crore already submitted. The company expects to win orders worth ₹10,000 crore by the end of the current financial year. The management is also confident of achieving 20% to 25% growth rate in the coming years. Bajaj Broking recommends buying the stock in the ₹498 – ₹518 range for an upside target of ₹670, a potential upside of 32% over the next 12 months.
